Ewing Sarcoma: Causes, Tests, and Treatment OptionsJP Smithson
Treatments for Ewing's Sarcoma What kind of treatment your child has depends on: The size of their tumor Where it has spread Their overall health Your preferences, which you should talk over with your doctor Treatment options include:
Ewing sarcoma is a pediatric bone and soft tissue tumor treated with chemotherapy, radiation, and surgery. Despite intensive multimodality therapy, ~50% patients eventually relapse and die of the disease due to chemoresistance. Here, using phospho-profiling, we find Ewing sarcoma cells treated with ...
Ewing's Sarcoma is a bone cancer that primarily affects children and teenagers. With a five-year survival rate of approximately 30%, improved treatment options are needed. Our research has focused on the ability of the synthetic cannabinoid, ajulemic acid, to induce death in Ewing's sarcoma ...
"I am encouraged by these initial data in relapsed/refractory Ewing sarcoma patients. This is a patient population with a high unmet need and limited effective treatment options," said Dr.Rashmi Chugh, MD, a Professor of Internal Medicine in the Div...
Ewing sarcoma; outcome; platinum; prognostic factor; retrospective Abstract Background Patients with Ewing sarcoma (EWS) who develop refractory or relapsed disease have limited treatment options. In some sarcoma centres in Europe the combination of etoposide with carbo- or cisplatin is being used for ...
Ewing's sarcoma /Primitive neuroectodermal tumours (ES/PNET) are categorized as small round cell tumours which commonly occur in bone and soft-tissue. Primary renal ES/PNET are uncommon with less than 150 cases reported till date. We received 1575 tumour nephrectomy specimens (radical and partial...
Ewing’s sarcoma (ES) is a rare and highly aggressive malignant tumor arising from bone and soft tissue. Suffering from intractable or recurrent diseases, the patients’ therapy options are very limited. It is extremely urgent to identify novel potential therapeutic targets for ES and put them in...
Ewing sarcoma (EWS) is an aggressive mesenchymal tumor with unmet clinical need and significant social impacts on children, adolescents, and young adults. CD99, a hallmark surface molecule of EWS, participates in crucial biological processes including cell migration, differentiation, and death. EWS ce...
For children with Ewing sarcoma, an aggressive bone cancer, a combination of two different classes of drugs may work synergistically to turn off the drivers fueling this disease, finds a new study. The combination appears to be more powerful than relying